Market Insights report
Cannabis-based medical products are used when encountering a variety of symptoms and illnesses. With ongoing product development, investments, and Mergers & Acquisitions, the field of use can still be expanded.
The Medical Cannabis market includes cannabinoid-based medicine, either licensed or unlicensed (not holding marketing authorization), which is supplied through the healthcare system and prescribed by a doctor with the primary focus of mitigating serious disease symptoms.
What's included?
This Report on the Medical Cannabis market provides detailed insights into the Medical Cannabis market from a global perspective. Besides all relevant market figures like worldwide revenues from 2016 to 2028, we have deep-dived into regional and country comparisons with a focus on Europe and the Americas.
The Medical Cannabis market was valued at 10.92 billion USD in 2022 and is expected to grow steadily between 2022 and 2028. The increase in usage and product diversity of cannabis-based medical drugs along with legalization in more countries are driving the market. The largest markets include developed countries including the US, Canada, Germany, and Australia.
Overview
Market numbers
We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)